Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1379322-06-1

Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate, a chemical compound with the molecular formula C10H20N2O3, is a tert-butyl carbanate derivative featuring a substituted oxetane ring and an amino group. This versatile building block is known for its unique structural properties, making it a valuable component in the synthesis of a wide range of organic compounds, particularly in the development of new pharmaceuticals and agrochemicals.

1379322-06-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1379322-06-1 Structure

  • Basic information

    1. Product Name: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate
    2. Synonyms: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate;tert-Butyl N-[(3-aminooxetan-3-yl)methyl]carbamate;(3-Amino-oxetan-3-ylmethyl)-carbamic acid tert-butyl ester
    3. CAS NO:1379322-06-1
    4. Molecular Formula: C9H18N2O3
    5. Molecular Weight: 202.25082
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1379322-06-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C(protect from light)
    8. Solubility: N/A
    9. CAS DataBase Reference: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(CAS DataBase Reference)
    10. NIST Chemistry Reference: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(1379322-06-1)
    11. EPA Substance Registry System: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(1379322-06-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1379322-06-1(Hazardous Substances Data)

1379322-06-1 Usage

Uses

Used in Organic Synthesis:
Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate is used as a reagent in organic synthesis for the preparation of various pharmaceuticals and agrochemicals. Its unique structural properties contribute to the creation of diverse organic compounds, enhancing the development of new drugs and functional materials.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate is utilized as a key intermediate in the synthesis of drugs. Its presence in the molecular structure can influence the pharmacological properties of the final product, making it an essential component in drug discovery and development.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate serves as a crucial intermediate for the synthesis of various agrochemicals. Its role in the development of effective and safe agrochemicals is vital for agricultural productivity and pest control.
Used as an Antiparasitic Agent:
Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate has been studied for its potential as an antiparasitic agent. Its unique structure may offer new avenues for the treatment of parasitic infections, providing an alternative to existing therapies.
Used as an Antifungal Agent:
Additionally, Tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate has shown promise as an antifungal agent. Its potential to combat fungal infections could lead to the development of new antifungal drugs, addressing the growing need for effective treatments against resistant fungal strains.

Check Digit Verification of cas no

The CAS Registry Mumber 1379322-06-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,9,3,2 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1379322-06:
(9*1)+(8*3)+(7*7)+(6*9)+(5*3)+(4*2)+(3*2)+(2*0)+(1*6)=171
171 % 10 = 1
So 1379322-06-1 is a valid CAS Registry Number.

1379322-06-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl ((3-aminooxetan-3-yl)methyl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl N-[(3-aminooxetan-3-yl)methyl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1379322-06-1 SDS

1379322-06-1Downstream Products

1379322-06-1Relevant articles and documents

Oxetanyl Amino Acids for Peptidomimetics

M?ller, Guido P.,Müller, Steffen,Wolfst?dter, Bernd T.,Wolfrum, Susanne,Schepmann, Dirk,Wünsch, Bernhard,Carreira, Erick M.

, p. 2510 - 2513 (2017)

Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics.

ALKYLBORONIC ACIDS AS ARGINASE INHIBITORS

-

Page/Page column 65, (2020/08/22)

Provided are alkylboronic acids as arginase inhibitors represented by formula (I), or a pharmaceutically acceptable salt, stereoisomer, tautomer, or prodrug thereof and a pharmaceutical composition comprising said compounds.

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

-

, (2016/11/07)

The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, X, R1, R2, R3 and R4 are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE

-

, (2013/04/13)

The invention relates to the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2 and X are as defined in the description and claims, which are useful for the treatment or prophylaxis of RSV infection.

COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE

-

, (2013/04/25)

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1, R2 and X are as defined in description and in claims, can be used as a medicament.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1379322-06-1